CN103926398A - 一种免疫磁珠的制备方法 - Google Patents
一种免疫磁珠的制备方法 Download PDFInfo
- Publication number
- CN103926398A CN103926398A CN201410181299.5A CN201410181299A CN103926398A CN 103926398 A CN103926398 A CN 103926398A CN 201410181299 A CN201410181299 A CN 201410181299A CN 103926398 A CN103926398 A CN 103926398A
- Authority
- CN
- China
- Prior art keywords
- magnetic bead
- preparation
- carboxyl
- immunomagnetic beads
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011324 bead Substances 0.000 title claims abstract description 179
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 230000005291 magnetic effect Effects 0.000 claims abstract description 148
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 56
- 239000000243 solution Substances 0.000 claims abstract description 41
- 238000005406 washing Methods 0.000 claims abstract description 38
- 239000007987 MES buffer Substances 0.000 claims abstract description 28
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000003756 stirring Methods 0.000 claims abstract description 13
- 239000003495 polar organic solvent Substances 0.000 claims abstract description 12
- 239000008367 deionised water Substances 0.000 claims abstract description 11
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 11
- 150000001718 carbodiimides Chemical class 0.000 claims abstract description 10
- 230000008569 process Effects 0.000 claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- 230000003213 activating effect Effects 0.000 claims abstract description 7
- 230000008878 coupling Effects 0.000 claims abstract description 7
- 238000010168 coupling process Methods 0.000 claims abstract description 7
- 238000005859 coupling reaction Methods 0.000 claims abstract description 7
- 239000002244 precipitate Substances 0.000 claims abstract description 4
- 239000002270 dispersing agent Substances 0.000 claims abstract description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 54
- 239000000377 silicon dioxide Substances 0.000 claims description 27
- 239000002105 nanoparticle Substances 0.000 claims description 20
- 239000002245 particle Substances 0.000 claims description 20
- 238000001514 detection method Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 10
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 9
- 238000001132 ultrasonic dispersion Methods 0.000 claims description 9
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 8
- 230000009514 concussion Effects 0.000 claims description 7
- 230000005415 magnetization Effects 0.000 claims description 7
- 230000007480 spreading Effects 0.000 claims description 7
- 238000003892 spreading Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 6
- 239000012498 ultrapure water Substances 0.000 claims description 6
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 5
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 5
- 230000004913 activation Effects 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000006148 magnetic separator Substances 0.000 claims description 5
- 229940005654 nitrite ion Drugs 0.000 claims description 5
- 239000013049 sediment Substances 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 5
- 229940038773 trisodium citrate Drugs 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 4
- -1 Polyethylene Polymers 0.000 claims description 4
- 239000012190 activator Substances 0.000 claims description 4
- 229910052786 argon Inorganic materials 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 238000002965 ELISA Methods 0.000 claims description 3
- 239000008118 PEG 6000 Substances 0.000 claims description 3
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims description 3
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000006392 deoxygenation reaction Methods 0.000 claims description 3
- 235000019441 ethanol Nutrition 0.000 claims description 3
- XQSBLCWFZRTIEO-UHFFFAOYSA-N hexadecan-1-amine;hydrobromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[NH3+] XQSBLCWFZRTIEO-UHFFFAOYSA-N 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 claims description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 230000001186 cumulative effect Effects 0.000 claims description 2
- 238000013016 damping Methods 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 239000005543 nano-size silicon particle Substances 0.000 claims description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229940014800 succinic anhydride Drugs 0.000 claims description 2
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000010923 batch production Methods 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 150000004702 methyl esters Chemical class 0.000 abstract 1
- 229910052710 silicon Inorganic materials 0.000 abstract 1
- 239000010703 silicon Substances 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
- BPKMOBSWRKNYIH-UHFFFAOYSA-N sodium;azide;hydrate Chemical compound O.[Na+].[N-]=[N+]=[N-] BPKMOBSWRKNYIH-UHFFFAOYSA-N 0.000 abstract 1
- 238000009210 therapy by ultrasound Methods 0.000 abstract 1
- 239000000427 antigen Substances 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 230000000694 effects Effects 0.000 description 7
- 239000007790 solid phase Substances 0.000 description 7
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 3
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000007885 magnetic separation Methods 0.000 description 3
- 230000005389 magnetism Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- BEGBSFPALGFMJI-UHFFFAOYSA-N ethene;sodium Chemical group [Na].C=C BEGBSFPALGFMJI-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000002122 magnetic nanoparticle Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 238000004375 physisorption Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Compounds Of Iron (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
免疫磁珠项目 | 背景值 | 样品 |
人IgG磁珠 | 0.005 | 2.303 |
甲胎蛋白磁珠 | 0.002 | 1.943 |
甲肝抗原磁珠 | 0.019 | 1.841 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410181299.5A CN103926398B (zh) | 2014-04-30 | 2014-04-30 | 一种免疫磁珠的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410181299.5A CN103926398B (zh) | 2014-04-30 | 2014-04-30 | 一种免疫磁珠的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103926398A true CN103926398A (zh) | 2014-07-16 |
CN103926398B CN103926398B (zh) | 2015-09-16 |
Family
ID=51144694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410181299.5A Active CN103926398B (zh) | 2014-04-30 | 2014-04-30 | 一种免疫磁珠的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103926398B (zh) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105418730A (zh) * | 2015-11-13 | 2016-03-23 | 洛阳惠尔纳米科技有限公司 | 一种基于磁珠法的抗体纯化方法 |
CN106018798A (zh) * | 2016-08-03 | 2016-10-12 | 武汉中科志康生物科技有限公司 | 一种免疫层析检测磁性颗粒及其制备方法 |
CN106366194A (zh) * | 2016-08-26 | 2017-02-01 | 上海交通大学 | 一种用于外周血淋巴细胞分离的免疫磁珠及其制备与应用 |
CN106468632A (zh) * | 2015-08-16 | 2017-03-01 | 复旦大学 | 一种磁性纳米材料及其制备方法和用途 |
CN106841611A (zh) * | 2017-02-15 | 2017-06-13 | 四川大学 | 一种基于ibv串联抗原s‑m‑n的免疫磁性微球‑elisa检测ibv抗体的方法 |
CN107478823A (zh) * | 2017-08-01 | 2017-12-15 | 长沙理工大学 | 一种基于乙酰胆碱酯酶信号放大原理检测双酚a的方法 |
CN107552021A (zh) * | 2017-09-28 | 2018-01-09 | 青岛科技大学 | 一种羟基生物磁珠及其制备方法和应用 |
CN108008125A (zh) * | 2017-12-18 | 2018-05-08 | 江苏浩欧博生物医药股份有限公司 | 一种适用于免疫磁珠的冻干工作液和免疫磁珠冻干品及其制备方法 |
CN109270064A (zh) * | 2018-11-12 | 2019-01-25 | 新乡医学院 | 一种基于葡聚糖微球的免疫沉淀试剂及其制备方法与应用 |
CN111205979A (zh) * | 2020-03-09 | 2020-05-29 | 山西大学 | 一种rna提取装置及方法 |
CN111484975A (zh) * | 2020-04-29 | 2020-08-04 | 上海轩锋生物科技有限公司 | 一种人t细胞cd3/cd28激活磁珠的制备方法 |
CN111662869A (zh) * | 2020-06-02 | 2020-09-15 | 北京康思润业生物技术有限公司 | 用于分离红细胞的免疫磁珠及其制备方法和应用 |
CN111999158A (zh) * | 2019-05-11 | 2020-11-27 | 南京岚煜生物科技有限公司 | 一种磁珠混匀的方法 |
CN112213174A (zh) * | 2019-07-12 | 2021-01-12 | 南京岚煜生物科技有限公司 | 一种采用磁性材料进行混匀的方法 |
CN113121636A (zh) * | 2021-04-08 | 2021-07-16 | 山东大丰园农业有限公司 | 用于富集正三十醇结合物的复合体及其制备方法与应用 |
CN115212860A (zh) * | 2022-06-30 | 2022-10-21 | 苏州为度生物技术有限公司 | 羧基化四氧化三铁@碳磁性微球及其制备方法和应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63189473A (ja) * | 1987-01-30 | 1988-08-05 | Yoshiyuki Ogushi | 表面塗布剤 |
CN100999559A (zh) * | 2007-01-04 | 2007-07-18 | 吉林大学 | 一种磁性粒子/聚合物/二氧化硅结构磁性微球的制备方法 |
CN101306841A (zh) * | 2007-05-16 | 2008-11-19 | 台湾圆点奈米技术开发有限公司 | 超顺磁性粒子及其制造方法 |
CN101323454A (zh) * | 2008-07-28 | 2008-12-17 | 陕西师范大学 | 表面螯合金属离子的磁性二氧化硅微球制备方法及其用途 |
CN101684138A (zh) * | 2008-09-26 | 2010-03-31 | 上海裕隆生物科技有限公司 | 一种应用纳米磁珠纯化核酸的试剂盒 |
CN103357359A (zh) * | 2013-05-16 | 2013-10-23 | 英科新创(厦门)科技有限公司 | 一种复合免疫磁微粒及其制备方法 |
CN103667483A (zh) * | 2013-12-06 | 2014-03-26 | 东南大学 | 一种基于磁分离的HBsAg核酸适体筛选方法 |
-
2014
- 2014-04-30 CN CN201410181299.5A patent/CN103926398B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63189473A (ja) * | 1987-01-30 | 1988-08-05 | Yoshiyuki Ogushi | 表面塗布剤 |
CN100999559A (zh) * | 2007-01-04 | 2007-07-18 | 吉林大学 | 一种磁性粒子/聚合物/二氧化硅结构磁性微球的制备方法 |
CN101306841A (zh) * | 2007-05-16 | 2008-11-19 | 台湾圆点奈米技术开发有限公司 | 超顺磁性粒子及其制造方法 |
CN101323454A (zh) * | 2008-07-28 | 2008-12-17 | 陕西师范大学 | 表面螯合金属离子的磁性二氧化硅微球制备方法及其用途 |
CN101684138A (zh) * | 2008-09-26 | 2010-03-31 | 上海裕隆生物科技有限公司 | 一种应用纳米磁珠纯化核酸的试剂盒 |
CN103357359A (zh) * | 2013-05-16 | 2013-10-23 | 英科新创(厦门)科技有限公司 | 一种复合免疫磁微粒及其制备方法 |
CN103667483A (zh) * | 2013-12-06 | 2014-03-26 | 东南大学 | 一种基于磁分离的HBsAg核酸适体筛选方法 |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106468632B (zh) * | 2015-08-16 | 2019-12-20 | 复旦大学 | 一种磁性纳米材料及其制备方法和用途 |
CN106468632A (zh) * | 2015-08-16 | 2017-03-01 | 复旦大学 | 一种磁性纳米材料及其制备方法和用途 |
CN105418730A (zh) * | 2015-11-13 | 2016-03-23 | 洛阳惠尔纳米科技有限公司 | 一种基于磁珠法的抗体纯化方法 |
CN106018798A (zh) * | 2016-08-03 | 2016-10-12 | 武汉中科志康生物科技有限公司 | 一种免疫层析检测磁性颗粒及其制备方法 |
CN106366194A (zh) * | 2016-08-26 | 2017-02-01 | 上海交通大学 | 一种用于外周血淋巴细胞分离的免疫磁珠及其制备与应用 |
CN106841611A (zh) * | 2017-02-15 | 2017-06-13 | 四川大学 | 一种基于ibv串联抗原s‑m‑n的免疫磁性微球‑elisa检测ibv抗体的方法 |
CN107478823A (zh) * | 2017-08-01 | 2017-12-15 | 长沙理工大学 | 一种基于乙酰胆碱酯酶信号放大原理检测双酚a的方法 |
CN107478823B (zh) * | 2017-08-01 | 2019-05-24 | 长沙理工大学 | 一种基于乙酰胆碱酯酶信号放大原理检测双酚a的方法 |
CN107552021B (zh) * | 2017-09-28 | 2020-05-15 | 青岛科技大学 | 一种羟基生物磁珠及其制备方法和应用 |
CN107552021A (zh) * | 2017-09-28 | 2018-01-09 | 青岛科技大学 | 一种羟基生物磁珠及其制备方法和应用 |
CN108008125A (zh) * | 2017-12-18 | 2018-05-08 | 江苏浩欧博生物医药股份有限公司 | 一种适用于免疫磁珠的冻干工作液和免疫磁珠冻干品及其制备方法 |
CN109270064B (zh) * | 2018-11-12 | 2020-12-01 | 新乡医学院 | 一种基于葡聚糖微球的免疫沉淀试剂及其制备方法与应用 |
CN109270064A (zh) * | 2018-11-12 | 2019-01-25 | 新乡医学院 | 一种基于葡聚糖微球的免疫沉淀试剂及其制备方法与应用 |
CN111999158A (zh) * | 2019-05-11 | 2020-11-27 | 南京岚煜生物科技有限公司 | 一种磁珠混匀的方法 |
CN112213174A (zh) * | 2019-07-12 | 2021-01-12 | 南京岚煜生物科技有限公司 | 一种采用磁性材料进行混匀的方法 |
CN111205979A (zh) * | 2020-03-09 | 2020-05-29 | 山西大学 | 一种rna提取装置及方法 |
CN111205979B (zh) * | 2020-03-09 | 2021-09-14 | 山西大学 | 一种rna提取装置及方法 |
CN111484975A (zh) * | 2020-04-29 | 2020-08-04 | 上海轩锋生物科技有限公司 | 一种人t细胞cd3/cd28激活磁珠的制备方法 |
CN111662869A (zh) * | 2020-06-02 | 2020-09-15 | 北京康思润业生物技术有限公司 | 用于分离红细胞的免疫磁珠及其制备方法和应用 |
CN113121636A (zh) * | 2021-04-08 | 2021-07-16 | 山东大丰园农业有限公司 | 用于富集正三十醇结合物的复合体及其制备方法与应用 |
CN115212860A (zh) * | 2022-06-30 | 2022-10-21 | 苏州为度生物技术有限公司 | 羧基化四氧化三铁@碳磁性微球及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103926398B (zh) | 2015-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103926398B (zh) | 一种免疫磁珠的制备方法 | |
CN108620048B (zh) | 聚乙烯亚胺修饰的磁性微球制备方法及应用 | |
Smith et al. | Optimization of antibody-conjugated magnetic nanoparticles for target preconcentration and immunoassays | |
Liu et al. | Preparation and characterization of amino–silane modified superparamagnetic silica nanospheres | |
US4018886A (en) | Diagnostic method and device employing protein-coated magnetic particles | |
CN104614535B (zh) | 甲状腺微粒体抗体检测试剂盒及其制备方法和应用 | |
CN106215821B (zh) | 一种磁微粒化学发光免疫分析试剂用羧基磁珠的制备方法 | |
CN108982834B (zh) | 纳米酶免疫夹心新技术检测生物分子的方法 | |
Cui et al. | The synthesis of GoldMag nano-particles and their application for antibody immobilization | |
WO1991002083A1 (en) | Manipulation of colloids for facilitating magnetic separations | |
Rashid et al. | Effective surface modification of MnFe2O4@ SiO2@ PMIDA magnetic nanoparticles for rapid and high-density antibody immobilization | |
CN104133067B (zh) | 一种基于磁性Fe3O4Au复合纳米材料电化学检测人免疫球蛋白E的方法 | |
US10705079B2 (en) | Method for preparing magnetic microsphere for separation of biological protein and use thereof | |
KR20210046667A (ko) | 자성 입자 | |
CN104913963B (zh) | 应用于免疫检测和免疫诊断领域的免疫磁珠的制备方法 | |
US9766237B2 (en) | Method of capturing bacteria on polylysine-coated microspheres | |
Li et al. | Preparation of novel bovine hemoglobin surface-imprinted polystyrene nanoparticles with magnetic susceptibility | |
CN115825427A (zh) | 一种降低磁珠非特异吸附的方法及其制备的磁珠和应用 | |
CN108802015A (zh) | 一种基于肽传感器的玉米赤霉烯酮无毒电化学发光传感器的制备 | |
JPH0763761A (ja) | 生理活性物質固定化磁性微粒子の製造法 | |
CN111167409A (zh) | Ni-NTA修饰的二氧化硅包覆四氧化三铁磁性纳米功能组装体的制备方法及应用 | |
CN114426971B (zh) | 一种基于DNAzyme辅助信号放大的荧光免疫分析方法 | |
CN105181956B (zh) | 基于金属离子特异响应的荧光检测法在免疫检测中的应用 | |
CN105717288B (zh) | 一种表面修饰的磁性纳米颗粒及其制备方法与应用 | |
Liu et al. | Deep-learning assisted zwitterionic magnetic immunochromatographic assays for multiplex diagnosis of biomarkers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210608 Address after: Room 320b, block a, software park, 228 Nanyi Road, Dongying District, Dongying City, Shandong Province 257000 Patentee after: Shandong Xinding Technology Co.,Ltd. Address before: 471003 company yard at the Northeast point of the intersection of Heluo road and Lingbo Road, high tech Zone, Luoyang City, Henan Province Patentee before: LUOYANG HUIER NANO TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230921 Address after: Room 701, Building 4, No. 236 Chuangyuan Road, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone, Suzhou City, Jiangsu Province, 215000 Patentee after: Suzhou Paibosi Biotechnology Co.,Ltd. Address before: Room 320b, block a, software park, 228 Nanyi Road, Dongying District, Dongying City, Shandong Province 257000 Patentee before: Shandong Xinding Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |